Vesilute
Also known as: ED, Glu-Asp, L-Glu-L-Asp, Bladder Peptide
ED Dipeptide | Bladder & Urinary Tract Bioregulator
Overview
Vesilute is a Khavinson bioregulator dipeptide consisting of glutamic acid and aspartic acid (ED), developed at the St. Petersburg Institute of Bioregulation and Gerontology. It is specifically designed to support bladder and urinary tract function, with research indicating potential benefits for prostate health in men. Vesilute may help regulate smooth muscle function, enhance tissue blood flow, and support cellular regeneration in urogenital tissues. It is distinct from Vesugen (KED tripeptide), which targets vascular endothelium.
Key benefits
- Supports bladder and urinary tract function
- May improve prostate health in men
- Regulates smooth muscle function
- Enhances pelvic tissue blood flow
- Supports cellular regeneration
- Part of comprehensive Khavinson bioregulator protocols
- Well-tolerated in research
- Oral bioavailability as small dipeptide
Mechanism of action
Vesilute acts on the smooth muscle cells and vascular endothelium of the urogenital system. It is proposed to: (1) regulate smooth muscle contraction and relaxation in the bladder wall, (2) enhance microcirculation and blood flow in pelvic tissues including prostate, (3) support cellular regeneration and tissue repair in the urinary tract, (4) reduce hyperemia and inflammation-related dysfunction, and (5) modulate gene expression related to urogenital tissue homeostasis through bioregulation pathways characteristic of Khavinson peptides.
Molecular data
- Type
- Dipeptide bioregulator
- Half-life
- Not established
Sequence
Glu-Asp (ED)
Indications
What the research community uses this compound for, with self-reported effectiveness.
Urinary Tract Health
Bladder Function Support
ModerateResearch explores relief of symptoms associated with bladder dysfunction through smooth muscle regulation.
Urinary Tract Health
ModerateMay support overall urinary tract function and tissue health.
Pelvic Floor Support
EmergingPotential benefits for pelvic tissue health and function.
Prostate Health (Men)
Prostate Support
ModerateResearch indicates potential to enhance blood flow and reduce dysfunction in prostate tissue.
BPH Symptoms
EmergingMay help alleviate symptoms associated with benign prostatic hyperplasia.
Anti-Aging Protocol
Urogenital Aging
ModeratePart of comprehensive bioregulator protocols addressing age-related urogenital changes.
Tissue Regeneration
EmergingSupports cellular regeneration in urinary and reproductive tissues.
Dosing protocols
Common protocols by delivery method. Adjust the curve below to model accumulation in your own cycle.
Injectable
Injectable form for subcutaneous or intramuscular administration. Standard Khavinson protocol of 10-20 day cycles, repeated 2-3 times per year for maintenance.
| Protocol | Dose | Frequency | Route / duration |
|---|---|---|---|
| Standard protocol | 10-20 mg | Daily for 10-20 days | SubQ or IM |
| Maintenance | 20 mg | 2-3 cycles yearly | SubQ or IM |
Preparation
You will need
- Bacteriostatic water
- Insulin syringes
- Alcohol swabs
- Sterile vial
Steps
- Clean work area thoroughly
- Reconstitute with bacteriostatic water
- Inject water slowly down vial wall
- Gently swirl until dissolved
- Store refrigerated at 2-8°C
- Use within 4 weeks of reconstitution
Work out the water volume and syringe units in the reconstitution calculator →
Oral
Oral capsule form may be available. As a small dipeptide, Vesilute has reasonable oral bioavailability.
| Protocol | Dose | Frequency | Route / duration |
|---|---|---|---|
| Oral protocol | 10-20 mg | Daily for 10-20 days | Oral capsules |
Interactions
Pairwise interactions with other compounds you might be cycling — the same data behind the cycle builder's safety check.
Prostamax
SynergisticBoth target prostate/urogenital health; can be combined for comprehensive support.
Vesugen
CompatibleDifferent targets - Vesugen for vascular, Vesilute for bladder/prostate. Can be combined.
Libidon
SynergisticComplementary for male reproductive and urogenital health protocols.
Epitalon
CompatibleOften combined in comprehensive anti-aging bioregulator protocols.
Thymalin
CompatibleDifferent target systems; no known negative interactions.
Timeline
Typical week-by-week effects reported in clinical and observational data.
- During cycle
Tissue-specific effects begin; gene expression modulation
- Days 10-20
Cellular function optimization in target tissues
- Post-cycle
Effects persist due to bioregulation mechanisms
- Long-term
Cumulative benefits with regular cycling; tissue health maintenance
Safety
Reported adverse effects, contraindications, and what to monitor on cycle.
Common side effects
- Generally well-tolerated
- Injection site reactions (mild, if injectable)
- Minimal reported side effects
Rare side effects
- Allergic reactions (rare)
Stop signs — stop and seek advice
- Signs of allergic reaction
- Unusual urinary symptoms
- Unexpected changes in urination patterns
Contraindications
- Known hypersensitivity to peptide components
- Active urinary tract infection (treat first)
- Pregnancy or breastfeeding
- Prostate cancer (consult physician)
Monitoring
- Urinary symptoms and patterns
- Prostate health markers (PSA) if appropriate
- General well-being
Quality checks
What a legitimate product looks like, what should give pause, and what should make you stop.
Good signs
- White to off-white lyophilized powder
- Clear solution after reconstitution
- Certificate of analysis available
- Proper packaging and storage
Warning signs
- Unknown source or unverified purity
Stop signs — don't use
- Discolored powder
- Cloudy or particulate solution
- Damaged packaging
References
Primary literature and clinical-trial data informing this entry.
Khavinson Bioregulator Peptides: Organ-Specific Effects
St. Petersburg Institute of Bioregulation and Gerontology
Vesilute (ED dipeptide) targets bladder and urinary tract tissues with bioregulatory effects.
Short Peptides and Urogenital Function
Russian Medical Research
ED dipeptide influences smooth muscle and vascular function in urogenital tissues.
Bioregulators in Anti-Aging Medicine
Khavinson VKh et al. · Advances in Gerontology
Organ-specific peptide bioregulators including Vesilute support tissue-specific regeneration.
Last updated . How this page was sourced is described in the methodology.